Tetrabenazine FDA Approved for Huntington’s Disease
Aug 22nd, 2008 | By admin | Category: Health News FeedsRochester.edu - The U.S. Food and Drug Administration approved tetrabenazine in August 2008, the first drug approved for use in the United States to treat Huntington’s disease - a fatal, inherited neurodegenerative disorder for which there is no cure. The action comes about eight months after an advisory panel unanimously voted to advise FDA to [...]
If you're new here, you may want to subscribe to our RSS feed. Thanks for visiting!
